Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]
Phase 1 safety study of SGN-CD19A in various B-cell lymphomas has completed; the update summarizes safety results across multiple indication…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluated bendamustine plus ofatumumab in elderly patients with newly diagnosed diffuse large B-cell lymphoma who a…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Occupational Exposure to Pesticides in the Prognosis of Lymphomas
A clinical trial assessing the impact of occupational pesticide exposure on prognosis in patients with diffuse large B-cell lymphoma has bee…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab, cyclophosphamide, and G-CSF followed by combination chemotherapy with rituximab and GM-CSF for refractor…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluated the combination of inotuzumab ozogamicin with rituximab in patients with diffuse large B-cell lymphoma. The trial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) [Phase 3]
Phase 3 trial comparing obinutuzumab plus CHOP vs rituximab plus CHOP in CD20-positive diffuse large B-cell lymphoma was terminated with res…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL. [Phase 3]
Phase 3 trial comparing high-dose chemotherapy with autologous stem cell transplant versus R-CHOP in high-risk diffuse large B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 trial update evaluating everolimus in combination with rituximab and chemotherapy for newly diagnosed untreated diffuse large B-cell…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Thalidomide Maintenance Treatment in DLBCL [Phase 3]
Phase 3 clinical trial evaluating maintenance thalidomide in diffuse large B-cell lymphoma (DLBCL) is ongoing, with sponsor Nanfang Hospital…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy [Phase 3]
A Phase III trial evaluating RAD001 (everolimus) as adjuvant therapy in poor-risk diffuse large B-cell lymphoma after complete response to r…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) [Phase 2]
A Phase 2 trial evaluating whether gene expression markers can predict outcomes in patients with diffuse large B-cell lymphoma treated with …
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) [Phase 2]
Phase 2 trial evaluating nivolumab in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after autologous stem cell transplant fai…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of vorinostat, rituximab, ifosfamide, carboplatin, and etoposide in adults with relapsed/refracto…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bendamustine hydrochloride, rituximab, etoposide, and carboplatin in relapsed/refractory diffuse large B-cell lym…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a multi-modality approach combining Yttrium-90 ibritumomab tiuxetan, fludarabine, radiation therapy, and d…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
Phase 2 trial evaluating haploidentical donor bone marrow transplantation in patients with high-risk hematologic cancers; results completed …
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab
Biomarker analyses from patients with diffuse large B-cell lymphoma treated with combination chemotherapy with or without rituximab are repo…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of oral clofarabine in relapsed/refractory non-Hodgkin lymphoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 feasibility study evaluating the addition of bortezomib to the R-ICE chemotherapy regimen for relapsed or refractory diffuse large B…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating bendamustine plus rituximab in older patients with previously untreated diffuse large B-cell lymphoma has completed…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL [Phase 3]
A Phase 3 clinical trial compares high-dose intravenous methotrexate with intrathecal methotrexate for central nervous system prophylaxis in…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)
The trial update notes completion of a utility study in Diffuse Large B-Cell Lymphoma sponsored by Hoffmann-La Roche.